CJC-1295 + Ipamorelin Research Stack

CJC-1295 + Ipamorelin Research Stack combines a GHRH analog with a selective ghrelin-receptor agonist in one research bundle for growth-hormone-axis study. Every batch is HPLC-tested and ships with a batch-specific third-party Certificate of Analysis (COA) confirming identity and 99%+ purity. For laboratory and research use only. Not for human consumption. This product is not a drug, supplement, food, or cosmetic and is not intended to diagnose, treat, cure, or prevent any disease.

Research Applications

This stack pairs CJC-1295 (a long-acting GHRH analog) with Ipamorelin (a selective GH secretagogue), a combination frequently used in GH-axis research to study complementary stimulation of growth-hormone release. Laboratory models use the pair to examine synergistic secretagogue signaling and pulsatile GH dynamics. Each peptide is individually HPLC-verified.

Purity & Verification

Every lot is analyzed by reversed-phase HPLC and, where applicable, mass spectrometry to confirm compound identity and 99%+ purity. A batch-specific, third-party Certificate of Analysis (COA) is included in the product gallery so researchers can confirm purity and identity before use. Supplied as a lyophilized (freeze-dried) powder; store sealed, cool, dry, and protected from light, and reconstitute per standard laboratory handling. Fast, tracked shipping from within the United States.

Peptide Research & Literature

Both CJC-1295 and Ipamorelin have individually published pharmacology studies in peer-reviewed journals. Selected published literature includes:

• Teichman SL, et al. "Prolonged stimulation of growth hormone (GH) and insulin-like growth factor I secretion by CJC-1295, a long-acting analog of GH-releasing hormone, in healthy adults." Journal of Clinical Endocrinology & Metabolism, 2006. PMID: 16352683
• Raun K, et al. "Ipamorelin, the first selective growth hormone secretagogue." European Journal of Endocrinology, 1998. PMID: 9849822

These citations are provided for research reference only and do not imply any claim about the effects of this product.

Frequently Asked Questions

Why combine CJC-1295 and Ipamorelin in research?
They act on complementary pathways of the GH axis (GHRH and ghrelin receptors), making them a common research pairing for studying growth-hormone release.

Are both peptides verified?
Yes. Each is HPLC-verified to 99%+ purity with its own batch-specific third-party COA.

Is the stack more economical?
Yes, the bundle is priced below buying each peptide separately.

Is this for human use?
No. Both peptides are for laboratory research only.

What documentation comes with each order?
Each order includes batch-specific third-party Certificates of Analysis for both peptides in the stack.

Are these the same compounds referenced in the published research literature?
Yes. CJC-1295 and Ipamorelin are the same GHRH analog and selective GH secretagogue studied in the peer-reviewed literature cited above.

For laboratory and research use only. Not for human consumption. This product is not a drug, supplement, food, or cosmetic and is not intended to diagnose, treat, cure, or prevent any disease.